Skip over navigation
Banner
Directory
Directory Search
Jobs
Job Search Post a Job
Patient
Patient Resources Drug Development
History
Genealogy
Industry
 Directory
 WA History
Quick Links
 Directory
 Job Search
 History
 Advertising
 
Facilities
 

EquipNet Auction: Major Lab Site Closures, Assets from Cyclerion and Proteostasis, March 25


Washington Life Science Industry Directory

EquipNet Auction: Major Lab Site Closures, Formerly the Assets from Cyclerion and Proteostasis, March 25 @ 9 am EST

Target your advertising by state, region or nationwide for the same low rate

Banner Advertising | Event Advertising

Cerevast Therapeutics, Inc.


Cerevast Therapeutics, Inc.
11601 Willows Rd NE, Suite 100
Redmond, WA 98052
Cerevast Therapeutics, Inc.
 
Phone: (425) 821-1939
Fax: (425) 821-9313
Year Established:  2009
Main Contact: Bradford A. Zakes, President & CEO
 
Other Contacts:  Andrew Leo, VP, Quality
Anthony J. Alleman, COO
Patrick Bobbitt, VP, Clinical Affairs
Anthony J. Alleman, VP, Operations
Gordon Brandt, M.D., CMO
Kendall Stever, CFO
Andrew Leo, VP, Quality
Mike Rothmeyer, Senior VP, Global Sales and Marketing
Gordon Brandt, M.D, CMO
Andrew Leo, VP, Quality
Mark Moehring, Ph.D., CTO
W.J. Tyler, Ph.D., CSO
Anthony J. Alleman, COO
 
Company Description
Cerevast Therapeutics is a medical technology company with primary emphasis in the field of SonoLysis for the treatment acute ischemic stroke and other vascular disorders. This non-invasive treatment is administered with Cerevast’s proprietary ultrasonic headframe called the ClotBustTM-ER, an operator independent device that can be rapidly and easily deployed by virtually any emergency room staff to safely administer the ultrasound energy for SonoLysis therapy.


Main Industry Directory

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 1997 - 2021 Info.Resource, Inc. All rights reserved.
Privacy Policy . Cookie Policy . Terms of Use . About . Advertising

WashingtonLifeScience.com is owned and published by Info.Resource, Inc.